(Reuters) - Medtronic Plc has agreed to stop manufacturing and distributing its SynchroMed implantable drug pump, U.S. regulators said on Monday, a step toward resolving allegations that the company ...

Medtronic PLC has agreed to stop selling a pain-medication pump linked to patient deaths except in rare cases, after regulators accused the company of failing to address recurring problems with how ...

Medtronic has received FDA clearance for a new implantable pain management device that can be programmed wirelessly via a Samsung tablet. The Intellis system is designed to treat chronic pain by ...

Medtronic has issued an urgent medical device correction on its SynchroMed II implantable drug infusion pumps, warning that the batteries in certain devices might suddenly fail, according to a news ...

Medtronic’s SynchroMed II implantable drug pump device, which has been recalled three times in recent years and tied to 14 deaths, has continued to be problematic for the medtech company. A three-page ...

Medtronic plc (NYSE:MDT) initiated a recall Friday to address potential battery life issues with its insulin pumps. As of July 31, the company has advised customers to pay close attention to their ...

Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers Actionable Insights in a Secure Cloud Environment DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) ...

Mylan has rejected Teva’s unsolicited bid. Robert J. Coury, Mylan’s executive chairman, said Teva’s roughly $40 billion offer grossly undervalues the company and “would require Mylan’s shareholders to ...

DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received CE (Conformité Européenne) Mark approval for its Inceptiv™ closed-loop ...

LOS ANGELES (Reuters) - Medtronic Inc said on Wednesday that U.S. regulators classified its move to inform physicians about an increase in the rate of inflammatory mass cases in patients receiving ...